EGFR Inhibitors Extend Their Reach in Lung Cancer
Recent advances in EGFR inhibition include combinations to overcome resistance and approvals for newly diagnosed or early-stage lung cancers.
Progress Against Cancer
Recent advances in EGFR inhibition include combinations to overcome resistance and approvals for newly diagnosed or early-stage lung cancers.
This month, the editors selected studies comparing CAR T therapies for large B-cell lymphoma, assessing a new type of...
Treating seemingly inoperable liver tumors with neoadjuvant immunotherapy may make surgery more feasible.
This month, AACR's journals editors highlighted factors that may reduce pancreatic cancer risk, a new humanized mouse model, and...
August’s edition of Editors’ Picks includes biomarkers of immunotherapy response, individualized colorectal screening guidelines, and other exciting research.
New cervical cancer self-screening options and a portable blood test device could lead to changes in at-home cancer screening...
Clinical trials for dogs with cancer can extend the lives of our four-legged friends while revealing insights about cancer...
The AACR journal editors' picks for July 2024 include a review of the risks from CAR T-cell therapy, advances...
Researchers are making progress on genetic classification of sarcoma tumors, the use of T-cell therapy, and nanomedicine delivery.
